|
gptkb:Sinopharm_BIBP_COVID-19_vaccine
|
6 months after second dose
|
|
gptkb:Epaxal
|
6-12 months after first dose
|
|
gptkb:Pneumococcal_polysaccharide_vaccine
|
at least 5 years
|
|
gptkb:Tdap
|
every 10 years
|
|
gptkb:Johnson_&_Johnson_COVID-19_vaccine
|
2 months after initial dose
|
|
gptkb:Moderna_COVID-19_vaccine
|
at least 5 months after primary series
|
|
gptkb:Pfizer–BioNTech_COVID-19_vaccine
|
at least 5 months after second dose
|
|
gptkb:Pneumovax_23
|
at least 5 years between doses
|
|
gptkb:DTaP_vaccine
|
every 10 years (as Tdap for adults)
|
|
gptkb:Single_dose_(Johnson_&_Johnson)
|
2 months after initial dose
|
|
gptkb:PPSV23
|
at least 5 years after previous dose
|
|
gptkb:Td_vaccine
|
every 10 years
|
|
gptkb:Medigen_COVID-19_vaccine
|
at least 12 weeks after second dose
|
|
gptkb:tozinameran
|
at least 5 months after primary series
|
|
gptkb:TT_vaccine
|
every 10 years
|
|
gptkb:Pneumo_23
|
at least 5 years
|
|
gptkb:meningococcal_vaccine
|
every 5 years for high-risk groups
|
|
gptkb:Vi_polysaccharide_vaccine
|
every 2-3 years
|
|
gptkb:YF-VAX
|
every 10 years if continued risk
|
|
gptkb:Janssen_COVID-19_Vaccine
|
at least 2 months after primary dose
|